Can Gene Expression Profiles Predict Cancer Outcomes?
Yes, gene expression profiles can be used to predict cancer outcomes, including prognosis and response to treatment. For instance, the Oncotype DX test evaluates the expression of 21 genes to predict the likelihood of breast cancer recurrence and to guide treatment decisions. Similarly, the PAM50 test classifies breast cancers into intrinsic subtypes, providing insights into prognosis and treatment response.
